Massachusetts General Hospital- Site Number : 8400002

Boston, Massachusetts 02114

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Breast Cancer Metastatic, Pancreatic Carcinoma Metastatic

Studies at this site

• Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer — Stopped early
• Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors — Stopped early